Filing Flows › Rani Therapeutics Holdings (RANI) › Q2 2026 › vs Q1 2026
Rani Therapeutics Holdings (RANI) Q2 2026 vs Q1 2026 (quarter over quarter)
Rani Therapeutics Holdings's revenue rose $0 (0%) from $1.7M in Q1 2026 to $1.7M in Q2 2026.
Rani Therapeutics Holdings, Q2 2026: revenue $1.7M, operating margin -516.9%, net loss $8.4M, operating cash flow −$9.0M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.7M | $1.7M | $0 | 0% |
| Other income, net | $407K | $324K | $83K | +26% |
| Net loss | $8.4M | $8.0M | $406K | +5% |
| Costs & expenses | $10.5M | $10.0M | $489K | +5% |
| Operating costs | $10.5M | $10.0M | $489K | +5% |
| Research & development | $5.0M | $5.2M | −$144K | -3% |
| General & admin | $5.5M | $4.9M | $633K | +13% |
| Operating cash sources | $11.6M | $8.7M | $2.9M | +33% |
| Depreciation & amortization | $152K | $161K | −$9K | -6% |
| Share-based compensation | $2.4M | $2.1M | $340K | +16% |
| Cash used in operations | $9.0M | $6.5M | $2.5M | +39% |
| Net loss absorbed | $8.4M | $8.0M | $406K | +5% |
| Working capital & other | $3.2M | $727K | $2.5M | +338% |
Questions
How much did Rani Therapeutics Holdings's revenue grow quarter over quarter in Q2 2026?
Rani Therapeutics Holdings's revenue rose $0 (0%) from $1.7M in Q1 2026 to $1.7M in Q2 2026.